课题基金 / 基金详情

外泌体miR-381-3p调控血管生成促进CSM神经损伤修复的作用及机制

批准号:
82102317
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
郑伟鹏
依托单位:
学科分类:
创伤
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
郑伟鹏

项目摘要

结项摘要

相似基金

相关文献

中文摘要
既往研究证明外泌体miR参与血管新生及脊髓损伤后的神经修复。我们前期首先在CSM患者和动物模型减压术后发现外泌体miR-381-3p明显上调,且可促进内皮细胞增殖、迁移及血管生成。据此我们提出以下假设:外泌体miR-381-3p可调控血管生成促进CSM的神经修复。本项目拟研究CSM神经损伤修复过程中外泌体miR-381-3p的时序表达变化、表达的表观遗传学调控和血管生成相关基因相互关系;联合基因芯片和生物信息学预测分析miR-381-3p的新靶基因;GOF/LOF干预研究过表达或敲低miR-381-3p对内皮细胞增殖迁移与成管能力及相关基因表达谱变化;受精卵显微注射法构建miR-381-3p表达功能型和抑制型转基因小鼠,在体验证miR-381-3p对转基因小鼠脊髓损伤后神经修复的影响,阐明miR-381-3p调控血管形成、促进神经修复的机制,为CSM神经损伤的修复治疗提供理论依据和新靶点。
英文摘要
Previous studies have demonstrated that exosome miRNAs are involved in angiogenesis and nerve repair after spinal cord injury. We firstly found that exosome miR-381-3p was significantly upregulated in patients with cervical spondylotic myelopathy (CSM) and animal models after decompression. And exosome miR-381-3p could promote the proliferation, migration and angiogenesis of endothelial cells. Accordingly, we proposed the following hypothesis: abnormal expression of exosome miR-381-3p may play an important role in nerve repair of CSM via regulation of angiogenesis. This project aims to investigate the temporal changes of exosomes miR-381-3p expression during nerve injury repair in CSM, the epigenetic regulation of expression and the relationship between angiogenesis related genes. The new target genes of miR-381-3p will be predicted and confirmed by Oligo microarray and Target Scan bioinformatics, and target genes' functions will be preliminarily analyzed. The effects of overexpression or knockdown of miR-381-3p on endothelial cell proliferation, catheterization and migration, as well as related gene expression profiles will be investigated via GOF (gain-of-function) and LOF (loss-of-function) experiments. Transgenic mice with functional and inhibitory expressions of miR-381-3p will be constructed by microinjection of fertilized ovum. The effect of miR-381-3p on nerve repair of transgenic mice after spinal cord injury will be experimented. The current work is likely to lead to provide theoretical basis and new targets for the repair and treatment of nerve injury in CSM.
脊髓型颈椎病(CSM)术后神经功能修复的分子机制研究是近年来CSM领域的前沿研究热点,研究发现针对CSM诊断和治疗的关键分子靶点对于其精准治疗及预后具有重要意义。外泌体miR参与血管新生及脊髓损伤后的神经修复。前期研究表明在CSM患者和动物模型减压术后发现外泌体miR-381-3p明显上调,且可促进内皮细胞增殖、迁移及血管生成。本项目基于CSM神经修复这一临床难点,从miRNA靶向调控血管生成修复CSM的独特方式展开研究。本项目发现CSM动物模型miR-381-3p表达增加,经文献检索、RNA-Seq分析和筛选获得miR-381-3p调控血管生成的靶基因为HMGB1,细胞转染后,通过LOF 与GOF 干预后探索敲低及过表达miR-381-3p 对内皮细胞增殖、迁移以及成管等表型的影响及其相关基因的表达变化。在机制方面,研究结果显示miR-381-3p的过表达可下调HMGB1及其磷酸化水平进而调控细胞增殖。综上,本研究确定了miR-381-3p的靶基因HMGB1,并阐明miR-381-3p介导HMGB1调控内皮细胞功能障碍进而促进CSM后运动功能恢复的机制。本项目为临床上通过miR-381-3p调控内皮细胞功能障碍进而促进CSM运动功能的改善奠定理论基础,同时为基于干预靶基因的表达模式实现血管生成的精准调控策略提供新的分子靶标点。
国内基金
海外基金